Consultants portal

DCVMN is neither responsible nor liable for any statement made by the consultants listed in this database, nor for their past or future performance of work.

Area1

Area2

Area3

Area4

Area5

Country

Name

Action

Marketing

Marketing

Fundraising and International Financing Expertise

Fundraising and International Financing Expertise

Governance and Ethics

France

Miloud Kaddar

Log in to see the file (Members only)

Technologies

Technologies

Preclinical assays

Technologies

Clinical trials design

United States

Florian Schodel

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Argentina

Victor Maqueda

Log in to see the file (Members only)

Premises design, qualification and validation

Technologies

Technologies

Premises design, qualification and validation

Clinical trials design

Australia

David Buckley

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Technologies

India

Paramdeep Singh

Log in to see the file (Members only)

Technologies

Technologies

Preclinical assays

Preclinical assays

Premises design, qualification and validation

Belgium

Nicolas Havelange

Log in to see the file (Members only)

Technologies

Technologies

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

India

Anil Chawla

Log in to see the file (Members only)

Technologies

Premises design, qualification and validation

Clinical trials design

Premises design, qualification and validation

Premises design, qualification and validation

Netherlands

Jaap Koster

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Governance and Ethics

Australia

Stephen Williams

Log in to see the file (Members only)

Clinical trials design

Clinical trials design

Clinical trials design

Premises design, qualification and validation

Fundraising and International Financing Expertise

Italy

Simonetta Viviani

Log in to see the file (Members only)

Marketing

Fundraising and International Financing Expertise

Marketing

Fundraising and International Financing Expertise

Fundraising and International Financing Expertise

United States

Elizabeth Gardiner

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Technologies

Premises design, qualification and validation

Technologies

United States

Thomas Ransohoff

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Canada

Liliana Chocarro

Log in to see the file (Members only)

Technologies

Premises design, qualification and validation

Preclinical assays

Technologies

Preclinical assays

United States

John Hennessey, Jr.

Log in to see the file (Members only)

Premises design, qualification and validation

Technologies

Technologies

United States

Barry Rosenblatt

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Thailand

Alain Kupferman

Log in to see the file (Members only)

Technologies

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Germany

Ute Krahl

Log in to see the file (Members only)

Technologies

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Brazil

Aldrey Oliveira

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

India

Vibin Joseph

Log in to see the file (Members only)

Marketing

Marketing

Marketing

Fundraising and International Financing Expertise

Fundraising and International Financing Expertise

United States

Kevin O'Neill

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

New Zealand

Maurice Parlane

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Argentina

Sandra Rumiano

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

South Africa

Maureen Dennehy

Log in to see the file (Members only)

Technologies

Technologies

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

INDIA

JAINENDRA JAIN

Log in to see the file (Members only)

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Preclinical assays

USA

Rajesh Gupta

Log in to see the file (Members only)

Marketing

Marketing

Marketing

Mexico

Sonia Villasenor

Log in to see the file (Members only)

Technologies

Technologies

Technologies

Technologies

Premises design, qualification and validation

India

Lajpat Sood

Log in to see the file (Members only)

Technologies

Preclinical assays

Preclinical assays

Switzerland

Nora Dellepiane

Log in to see the file (Members only)

Clinical trials design

Clinical trials design

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

France

Marie-Françoise SCHERRER-MAKADI

Log in to see the file (Members only)

Preclinical assays

Preclinical assays

Preclinical assays

Technologies

Technologies

Thailand

Rochapon Wacharotayankun

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Technologies

Technologies

Netherlands

Per Staugaard

Log in to see the file (Members only)

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Italy

Dario Cresci

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Marketing

The Netherlands

Philip Beek

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Singapore

Paul Huntly

Log in to see the file (Members only)

Technologies

Technologies

Premises design, qualification and validation

Preclinical assays

Technologies

Belgium

Jean Smal

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Technologies

Technologies

Premises design, qualification and validation

Switzerland

Alain Pralong

Log in to see the file (Members only)

Clinical trials design

Belgium

Andrea Lohee

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Marketing

Premises design, qualification and validation

Marketing

South Africa

Allan Thomas

Log in to see the file (Members only)

Clinical trials design

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Belgium

Pieter NEELS

Log in to see the file (Members only)

Clinical trials design

Clinical trials design

Premises design, qualification and validation

Premises design, qualification and validation

Belgium

Bernadette Hendrickx

Log in to see the file (Members only)

Technologies

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Technologies

India

Ganesh Kumraj

Log in to see the file (Members only)

Technologies

Premises design, qualification and validation

Technologies

Italy

Aldo Giannozzi

Log in to see the file (Members only)

Marketing

Marketing

Governance and Ethics

Governance and Ethics

USA

Mark Paxton

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Belgium

Toon De Kesel

Log in to see the file (Members only)

Fundraising and International Financing Expertise

Marketing

Governance and Ethics

switzerland

ilaria cameli

Log in to see the file (Members only)

Governance and Ethics

Premises design, qualification and validation

Fundraising and International Financing Expertise

Premises design, qualification and validation

Fundraising and International Financing Expertise

The Netherlands

Jan Hendriks

Log in to see the file (Members only)

Technologies

Technologies

USA

Rebecca Sheets

Log in to see the file (Members only)

Premises design, qualification and validation

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

The Netherlands

ian sykes

Log in to see the file (Members only)

Technologies

Preclinical assays

Clinical trials design

Premises design, qualification and validation

Premises design, qualification and validation

Chian

Allen Goldenthal

Log in to see the file (Members only)

Preclinical assays

Technologies

Technologies

Technologies

Premises design, qualification and validation

France

Jean CHAPSAL

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Marketing

Premises design, qualification and validation

Turkey

Mustafa Edik

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Preclinical assays

Premises design, qualification and validation

Switzerland

Drew Meek

Log in to see the file (Members only)

Fundraising and International Financing Expertise

Fundraising and International Financing Expertise

Marketing

Fundraising and International Financing Expertise

USA

Stephen Jarrett

Log in to see the file (Members only)

Clinical trials design

Clinical trials design

Clinical trials design

Clinical trials design

Premises design, qualification and validation

Switzerland

Katharina Hartmann

Log in to see the file (Members only)

Marketing

Marketing

Marketing

Marketing

Governance and Ethics

india

Ashish Agarwal

Log in to see the file (Members only)

Technologies

Technologies

Technologies

Preclinical assays

Preclinical assays

USA

Viliam Pavliak

Log in to see the file (Members only)

Governance and Ethics

Preclinical assays

Fundraising and International Financing Expertise

Switzerland

Laura Viviani

Log in to see the file (Members only)

Technologies

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

Premises design, qualification and validation

France

Philippe Robin

Log in to see the file (Members only)

Premises design, qualification and validation

Premises design, qualification and validation

Clinical trials design

Egypt

Mona Salem

Log in to see the file (Members only)

Marketing

Fundraising and International Financing Expertise

Marketing

Fundraising and International Financing Expertise

Marketing

India

Ganesh R

Log in to see the file (Members only)

Preclinical assays

United States

Stanley Deming

Log in to see the file (Members only)

Preclinical assays

Preclinical assays

Clinical trials design

Premises design, qualification and validation

Netherlands

Coenraad Hendriksen

Log in to see the file (Members only)

Technologies

Technologies

Technologies

Preclinical assays

Preclinical assays

United States

Juan Arciniega

Log in to see the file (Members only)

Marketing

Marketing

Technologies

Technologies

Governance and Ethics

China

Ke Wu

Log in to see the file (Members only)

Partners:

DCVMN

DCVMN is a voluntary public health driven alliance of vaccine manufacturers from developing countries that aims to make a consistent supply of high quality vaccines that are accessible to protect people against known and emerging infectious diseases globally.